Autori: Natosevic Sladjana
Naslov | Namodenoson in Advanced Hepatocellular Carcinoma and Child-Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial (Article) |
Autori | Stemmer Salomon M Manojlovic Nebojsa S ... Natosevic Sladjana ... (broj koautora 21) |
Info | CANCERS, (2021), vol. 13 br. 2, str. - |
Projekat | Can-Fite BioPharma, Ltd. |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
Naslov | A phase II, randomized, double-blind, placebo-controlled trial evaluating efficacy and safety of namodenoson (CF102), an A(3) adenosine receptor agonist (A(3)AR), as a second-line treatment in patients with Child-Pugh B (CPB) advanced hepatocellular carcinoma (HCC). (Meeting Abstract) |
Autori | Stemmer Salomon M Manojlovic Nebojsa S ... Natosevic Sladjana ... (broj koautora 20) |
Info | JOURNAL OF CLINICAL ONCOLOGY, (2019), vol. 37 br. 15, Suppl. S, str. - |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |